Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Apr 9, 2019 at 11:00 AM EDT

Chimerix Makes a Couple Big Changes at the Top

Chimerix shares jumped sharply on Tuesday after the firm announced that it would be making changes to its executive team.

Chris Lange | Apr 9, 2019 at 10:05 AM EDT

Bad News for Epilepsy Seizure Patients Following FDA Update

Zogenix shares were crushed on Tuesday after the firm provided an update from the FDA regarding Fintepla for the treatment…

Chris Lange | Apr 9, 2019 at 9:05 AM EDT

What’s Next for PhaseBio’s Antiplatelet Reversal Agent

PhaseBio shares made a sizeble gain on Tuesday morning after the FDA provided a critical update for the firm.

Chris Lange | Apr 8, 2019 at 11:10 AM EDT

Should Alnylam Pharma Be Getting More Credit for Its Regeneron Deal?

Alnylam Pharma and Regeneron Pharma shares dipped on Monday despite announcing a collaboration to discover, develop and commercialize new RNA…

Chris Lange | Apr 8, 2019 at 10:05 AM EDT

High Hopes for This Neulasta Biosimiliar for Cancer Treatment

Coherus BioSciences shares jumped on Monday morning after the firm released updated sales for its first quarter.

Chris Lange | Apr 5, 2019 at 9:20 AM EDT

Merrimack Discontinues Cancer Study Amidst Layoffs

Merrimack Pharmaceuticals shares dipped on Friday after the firm announced that it would be discontinuing one of its cancer drugs…

Paul Ausick | Apr 4, 2019 at 12:20 PM EDT

Do E-Cigarettes Cause Seizures in Young Users?

The FDA has issued a safety alert related to the use of e-cigarettes, especially among young Americans. The agency has…

Chris Lange | Apr 4, 2019 at 10:40 AM EDT

PTSD Treatment Looked at for Fibromyalgia

Tonix Pharmaceuticals shares jumped on Monday after the firm announced the expansion of its late-stage PTSD treatment.

Chris Lange | Apr 3, 2019 at 11:10 AM EDT

Drug Candidate Makes Big Strides in the Treatment of Parkinson’s Disease Cognitive Impairment

Aptinyx has announced positive preclinical data on its drug candidate demonstrating reversal of cognitive deficits in a nonhuman primate model…

Chris Lange | Apr 3, 2019 at 10:25 AM EDT

The Search for Next-Generation Medical Cannabis for PTSD, Chronic Pain and Cancer

Agricultural engineering firm Evogene has announced the establishment of a new subsidiary to develop next-generation medical cannabis products.

Paul Ausick | Apr 2, 2019 at 2:18 PM EDT

Opioid Prescriptions Are Down, So Why Are They Still Killing Americans?

A new study on prescription opioid use in the United States finds that while dosages and amounts are dropping, longer-term…

Chris Lange | Apr 2, 2019 at 11:40 AM EDT

What’s Next for Sangamo After This Hemophilia Study

Sangamo Therapeutics shares jumped on Tuesday after the company announced interim data from its midstage hemophilia trial in collaboration with…

Chris Lange | Apr 2, 2019 at 10:45 AM EDT

How Apyx Medical Was Crushed by the FDA

Apyx Medical shares dropped sharply on Tuesday after the company announced that it has voluntarily withdrawn its application for premarket…

Douglas A. McIntyre | Apr 2, 2019 at 6:20 AM EDT

Americans Borrowed $88 Billion for Health Care Last Year

Health care costs in the United States are generally measured as the highest in the world. Last year, many Americans…

Chris Lange | Mar 28, 2019 at 12:25 PM EDT

What’s Next for Tricida’s Chronic Kidney Disease Treatment

Tricida shares jumped on Thursday after the firm announced results from its chronic kidney disease study.

1 … 101 102 103 104 105 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Chimerix Makes a Couple Big Changes at the Top

Bad News for Epilepsy Seizure Patients Following FDA Update

What’s Next for PhaseBio’s Antiplatelet Reversal Agent

Should Alnylam Pharma Be Getting More Credit for Its Regeneron Deal?

High Hopes for This Neulasta Biosimiliar for Cancer Treatment

Merrimack Discontinues Cancer Study Amidst Layoffs

Do E-Cigarettes Cause Seizures in Young Users?

PTSD Treatment Looked at for Fibromyalgia

Drug Candidate Makes Big Strides in the Treatment of Parkinson’s Disease Cognitive Impairment

The Search for Next-Generation Medical Cannabis for PTSD, Chronic Pain and Cancer

Opioid Prescriptions Are Down, So Why Are They Still Killing Americans?

What’s Next for Sangamo After This Hemophilia Study

How Apyx Medical Was Crushed by the FDA

Americans Borrowed $88 Billion for Health Care Last Year

What’s Next for Tricida’s Chronic Kidney Disease Treatment

Is Jeff Bezos’ New Startup An Even Bigger Idea than Amazon? He Tells CNBC it Will Drive ‘Civilizational Wealth.’

Cramer Calls Intel the “Number One Name” and “More Important Than NVIDIA.” The Stock Soars Today After a Massive Double Upgrade.

‘I Feel Like It’s 1999 Again.’ CNBC Analyst Issues Dire Warning on Oracle Stock

Why Delaying Social Security While Emptying Your 401(k) Can Slash Your Lifetime Taxes

Retiring With $1.8M in New Jersey Means an $11,400 Annual Tax Bill the Calculators Skip

Is Jeff Bezos’ New Startup An Even Bigger Idea than Amazon? He Tells CNBC it Will Drive ‘Civilizational Wealth.’

Cramer Calls Intel the “Number One Name” and “More Important Than NVIDIA.” The Stock Soars Today After a Massive Double Upgrade.

Health and Healthcare Articles

All Health and Healthcare Articles

Chimerix Makes a Couple Big Changes at the Top

Bad News for Epilepsy Seizure Patients Following FDA Update

What’s Next for PhaseBio’s Antiplatelet Reversal Agent

Should Alnylam Pharma Be Getting More Credit for Its Regeneron Deal?

High Hopes for This Neulasta Biosimiliar for Cancer Treatment

Merrimack Discontinues Cancer Study Amidst Layoffs

Do E-Cigarettes Cause Seizures in Young Users?

PTSD Treatment Looked at for Fibromyalgia

Drug Candidate Makes Big Strides in the Treatment of Parkinson’s Disease Cognitive Impairment

The Search for Next-Generation Medical Cannabis for PTSD, Chronic Pain and Cancer

Opioid Prescriptions Are Down, So Why Are They Still Killing Americans?

What’s Next for Sangamo After This Hemophilia Study

How Apyx Medical Was Crushed by the FDA

Americans Borrowed $88 Billion for Health Care Last Year

What’s Next for Tricida’s Chronic Kidney Disease Treatment

Is Jeff Bezos’ New Startup An Even Bigger Idea than Amazon? He Tells CNBC it Will Drive ‘Civilizational Wealth.’

Cramer Calls Intel the “Number One Name” and “More Important Than NVIDIA.” The Stock Soars Today After a Massive Double Upgrade.

‘I Feel Like It’s 1999 Again.’ CNBC Analyst Issues Dire Warning on Oracle Stock

Featured Reads

Why Delaying Social Security While Emptying Your 401(k) Can Slash Your Lifetime Taxes

Retiring With $1.8M in New Jersey Means an $11,400 Annual Tax Bill the Calculators Skip